Posted by Maria-Professional Networkers on December 31, 2002 at 16:10:26:
In Reply to: Lymphangioleiomyomatosis posted by William Wise on December 31, 2002 at 00:25:03:
Hi William!
Lymphangioleiomyomatosis (LAM) is a rare lung disease that was first described in the medical literature 1937. The disease is characterized by an unusual type of muscle cell that invades the tissue of the lungs, including the airways, and blood and lymph vessels. Over time, these muscle cells form into bundles and grow into the walls of the airways, and blood and lymph vessels, causing them to become obstructed.
Although these cells are not considered cancerous, they act somewhat like cancer cells in that they grow uncontrollably throughout the lung. Over time, the muscle cells block the flow of air, blood, and lymph to and from the lungs, preventing the lungs from providing oxygen to the rest of the body.
Lymphangioleiomyomatosis is pronounced lim - fan' je - o - li' o - mi' o - ma - to' sis. Lymph and angio refer to the lymph and blood vessels. Leiomyomatosis refers to the formation of the bundles of the unusual muscle cells.
The cause of LAM is not known. Often when a cause is not known for a medical condition, scientist find that it is immune system related. Autoimmune diseases are on the rise. Many of our physicians recommend consuming TF for immune system support when the cause of the disorder is not known.
The progression of lymphangioleiomyomatosis is thought to be influenced by hormonal factors. The report "Decline in Lung Function in Lymphangioleiomyomatosis" (*See Link Below) provides some support for the suggestion that disease progression may be reduced by progesterone. This could bring into consideration the use of FemRite.
I hope this helps!
Maria
Distributor Relations